 |
CME SLIDES FORUM
Archive
 |
Genetic screening and transplant options
|
 |
The sensitized patient: screening tests and desensitization protocols - present and future
|
| Dr. P. Ruggenenti Renal Research Department Mario Negri Institute Bergamo, Italy |
Dr. J. Gloor |
||
 |
ABO incompatible kidney transplantation
|
 |
Pregnancy after transplantation
|
| Dr. H. Genberg Department of Transplantation Surgery Karolinska University Hospital Huddinge CLINTEC, Karolinska Institute Stockholm, Sweden |
Prof. M. Al-Rukhaimi Medical and Renal Department Dubai Hospital Dubai, UAE |
||
 |
Membranous and endocapillary (post-infections) glomerulonephritis
|
 |
Clinical aspects of the new IgA nephropathy classification
|
| Dr M.J. Mihatsch Institute for Patholopgy University Hospital Basel Basel, Switzerland |
Prof J. Feehally |
||
 |
Lupus nephritis classification: review and evaluation
|
 |
|
| Prof J.J. Weening Institute Pathology Tergooiziekenhuizen Blaricum, The Netherlands |
M.P. Rastaldi Renal Immunopathology Laboratory Fondazione D’Amico per la Ricerca sulle Malattie Renali San Carlo Hospital Milan, Italy |
||
 |
CKD is common, harmful and treatable
|
 |
Ageing: is that the true cardio-kidney-damage "CKD" challenge?
|
| Prof. Andrew S. Levey Division of Nephrology Tufts University School of Medicine Boston, USA |
Prof. A.M. El-Nahas |
||
 |
Cellular and molecular mechanisms of renal ageing and their importance for disease
|
|
|
| Prof. A. Melk Division of Pediatric Nephrology Gastroenterology and Metabolic Diseases Children's Hospital, Hannover Medical School Hannover, Germany |
|||
 |
The emerging role of epigenetics in health and disease
|
 |
Novel therapeutic approaches to diabetic nephropathy
|
| Prof
T. Ekström Department of Clinical Neuroscience Karolinska University Hospital at Solna Stockholm, Sweden |
Dr
T. Miyata |
||
 |
|
|
|
| Prof
R. Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy |
|||
 |
Update on the immunobiology in kidney transplantation
|
 |
|
| Dr. D. Abramowicz Nephrology Departmente Hopital Erasme Brussels, Belgium |
Dr Yves Vanrenterghem |
||
 |
New immunosuppressive drugs on the horizon
|
 |
|
| Dr. F. Vincenti Kidney Transplant Service University of California San Francisco, CA, USA |
Prof. D. Taube Department of Nephrology Hammersmith Hospital London, United Kingdom |
||
 |
Angio or MRI: advice for the nephrologist
|
 |
Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis
|
| Prof. P. Aspelin Division of Radiology Karolinska Institute Stockholm, Sweden |
Prof P. Marckmann |
||
 |
|
||
| Prof G. London Department of Nephrology Manhes Hospital Fleury-Merogis, France |
|||
|
 |
Induction and maintenance therapy
|
|
| Prof J.J. Weening Institute Pathology Tergooiziekenhuizen Blaricum, The Netherlands |
Prof C. Ponticelli |
||
 |
 |
||
| Prof D. Schlöndorff Mount Sinai School of Medicine Division of Nephrology New York, NY, USA |
Dr
H.-J. Anders Ludwig-Maximilians-Universitaet Med. Poliklinik, Klinikum Innenstadt Munich, Germany |
||
 |
The role of the fibrinolytic system in renal ischemiareperfusion injury |
||
| Dr
S. Florquin Dept. of Pathology Academic Medical Centre Amsterdam, The Netherlands |
|||
 |
 |
Intensified blood pressure control slows CKD progression in children. Final results of escape trial
|
|
| Dr.
R. Fagard Hypertension and Cardiovascular Rehabilitation Unit University of Leuven Leuven, Belgium |
Dr.
F. Schaefer |
||
 |
Mechanisms of renal and cardiovascular actions of vitamin D receptors |
 |
Vitamin D in CKD: 25 D, 1,25 D, or both?
|
| Prof. K. Olgaard Nephrology Department Rigshospitalet Copenhagen, Denmark |
Prof.
R. Thadhani |
||
 |
|||
| Prof.
A. Levin Clinical Professor of Medicine University of British Columbia Vancouver, Canada |
|||
 |
 |
New insights in capillary physiology
|
|
| Prof. R. Krediet Chief Division of Nephrology Academic Medical Centre Amsterdam, The Netherlands |
Prof. B. Rippe |
||
 |
 |
|
|
| Prof
H. Holtöfer Centre for Bioanalytical Sciences Dublin City University Dublin, Ireland |
Prof
P. Mathieson |
||
 |
The podocyte in diabetic nephropathy
|
|
|
| Prof P. Fioretto Department of Medical and Surgical Sciences University of Padova Padova, Italy |
|||
 |
Nutritional aspects of the critically ill ARF patients
|
 |
Timing of initiation and stopping of RRT in ARF
|
| Prof. E. Burdmann Division of Nephrology Sao Jose do Rio Preto Medical School Sao Jose do Rio Preto, SP Brazil |
Prof. W. Druml |
||
 |
Modality of RRT selection for AKI in the ICU
|
 |
AKI in critically ill paediatric patients
|
| Dr. M. Schneider Department of Nephrology Charité University Hospital Berlin, Germany |
Dr. S. Picca Department of Nephrology and Urology "Bambino Gesù" Pediatric Research Hospital Roma, Italy |
||
 |
Tissue protection in ischaemia
|
 |
Role of inflammatory cells in AKI
|
| Prof
D. Fliser Renal and Hypertensive Disease University Medical Centre Homburg/Saar, Germany |
Prof. M. De Broe |
||
 |
What the nephrologist needs to know about artificial ventilation
|
 |
Severe sepsis, septic shock and the kidney
|
| Dr. M. Schetz Dept of Intensive Care Medicine K.U. Leuven Leuven, Belgium |
Dr. E. Hoste Dept of Intensive Care Medicine Ghent University Hospital Ghent, Belgium |
||
|
Clinical features and treatment options for ARDS? | ||
| Dr. Z. Ricci Dept Pediatric Cardiology Pediatric Hospital "Bambino Gesù" Roma, Italy |
|||
 |
Antidiabetic treatment in diabetic patients with kidney disease
|
 |
The diabetic foot - diagnosis of the foot at risk and management of foot complications
|
| Prof
G. Schernthaner Dept. of Medicine I Rudolfstiftung Hospital Vienna, Austria |
Prof
K. Brismar |
||
 |
Rehabilitation and physical exercise of diabetic kidney patients
|
|
|
| Prof
N. Clyne Dept. of Medicine Soedertaelje Hospital Soedertaelje, Sweden |
|||
 |
Clinical assessment of endothelial dysfunction
|
 |
The (pro)renin receptor in cardiovascular and kidney disease
|
| Dr M.S. Goligorsky Renal Research Institute and Division of Nephrology New York Medical College Valhalla, NY, USA |
Dr. G. Nguyen |
||
 |
Molecular mechanisms in vascular calcification
|
|
|
| Prof. M. Ketteler Chefarzt der III. Med. Klinik Klinikum Coburg gGmbH Coburg, Germany |
|||
 |
Guidelines for reporting observational studies: the newly published strobe statement
|
 |
When are observational studies as strong as RCTS?
|
| Prof
C. Zoccali Unità di Nefrologia, Dialisi, Trapianto e Ipertensione OO.RR and CNR Istituto di Biomedicina Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Reggio Calabria, Italy |
Dr. F.W. Dekker |
||
 |
Observational studies revisited: designs, strengths and weaknesses
|
|
|
| Dr.
K.J. Jager ERA-EDTA Registry - Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands |
|||
 |
COSMOS: a picture of CKD-MBD in the European scenario
|
 |
Intracellular mechanisms of bone remodelling
|
| Prof J. Cannata-Andia Servicio de Metabolismo Oseo y Mineral Instituto “Reina Sofía” de Investigación. REDinREN – ISCIII. Hospital Universitario Central de Asturias. Universidad de Oviedo Oviedo, Spain |
Prof M.H. Lafage-Proust |
||
 |
An update on post-transplant bone disease
|
 |
What is the role of biphosphonates following kidney transplantation?
|
| Prof J. M. Frazao Nephrology Research and Development Unit School of Medicine, Porto University Porto, Portugal |
Prof J. Cunningham The Centre for Nephrology The Royal Free and University College, Medical School London, UK |
||
 |
|||
| Prof R. Wüthrich Division of Nephrology University Hospital Zürich Zürich, Switzerland |
|||
 |
|
|
|
| Prof G. Remuzzi Mario Negri Institute for Pharmacological Researches Negri Bergamo Laboratories Bergamo, Italy |
Prof J. Feehally |
||
 |
 |
Renal amyloidosis and monoclonal deposition diseases
|
|
| Prof C. Savage Renal Immunobiology Division of Immunity and Infection University of Birmingham Medical School Edgbaston, Birmingham, United Kingdom |
Prof P. Ronco INSERM Unit 702, University Pierre and Marie Curie Tenon Hospital Paris, France |
||
 |
Definition and epidemiology of the metabolic syndrome
|
 |
Insulin resistance in hypertension and kidney disease
|
| Prof A. Alvestrand Dept. of Clinical Science, Intervention and Technology Karolinska University Hospital Stockholm, Sweden |
Dr P.A. Sarafidis |
||
 |
 |
To what extent should we treat obesity in dialysis patients? |
|
| Dr S.J.L. Bakker Department of Internal Medicine University Medical Center Groningen Groningen, The Netherlands |
Dr R. de Mutsert Clinical Epidemiology Leiden University Medical Center Leiden, The Netherlands |
||
 |
|||
| Dr F. Mallamaci Nephrology, Dialysis, Transplantation and Hypertension Unit, OO.RR and CNR Istituto di Biomedicina, Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Reggio Calabria, Italy |
|||
 |
New elements in the role of ureamic toxins in arteriosclerosis
|
 |
Outcomes associated with modifiable dialysis unit practices in the DOPPS
|
| Prof
R. Vanholder Professor of Medicine at the University of Ghent, Belgium, Associate Head of the Nephrology Division of the Ghent University Hospital Ghent, Belgium |
Prof
Stefan H. Jacobson |
||
 |
|
 |
Atrial volume and atrial biomarkers: a risk stratification criterium in dialysis patients
|
| Prof Adrian Covic Full Professor of Nephrology Dialysis and Renal Transplantation Unit “C. I. Parhon” University Hospital Iasi, Romania |
Prof B. Canaud |
||
 |
Expansion of the living donor pool in europe-ethical considerations
|
 |
Current problems in transplantation in children
|
| Prof W. Weimar Department of Internal Medicine - Transplantation Erasmus Medical Center Rotterdam, The Netherlands |
Prof C. Holmberg |
||
 |
|
|
|
Prof U. Frei |
|||
 |
Rituximab as a rescue therapy in ciclosporine dependent/ resistant nephrotic syndrome |
 |
What can the clinician learn from protocol biopsies?
|
| Dr V. Guigonis Department of Pediatric Hopital de la Mère et de l'Enfant Limoges, France |
Dr M.J. Mihatsch |
||
 |
Management of chronic allograft nephropathy
|
|
|
Dr B. Fellstrom |
|||
 |
New hereditary basement membrane diseases: the brain–eye-kidney connection |
 |
Mechanisms of injury in uromodulin-associated kidney disease
|
| Prof E. Plaisier Service de Néphrologie and INSERM UMRS702 Hôpital Tenon Paris, France |
Dr Matthias T.F. Wolf |
||
|
Therapy with somatostatin analogues in ADPKD
|
|
|
Dr P. Ruggenenti |
|||
